The University of Florida Clinical and Translational Science Institute, in partnership with Florida State University, has been awarded $29 million to speed research discoveries that will lead to improved health for people living in the nation’s third-largest state.
UF and FSU will expand their research partnership with the five-year award, which is funded by the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) Program. Led by the National Center for Advancing Translational Sciences, the nationwide network of more than 50 CTSA hubs develop, demonstrate and disseminate advances in translational science, a field devoted to turning research discoveries into new approaches that improve health.
“As an integrated CTSA hub, UF and FSU can bring together our scientific strengths to better serve both of our communities and make a difference in the lives of all Floridians,” said CTSI director and CTSA principal investigator Dr. David R. Nelson, senior vice president for health affairs at UF and president of UF Health. “By combining complementary resources, we can engage more people as partners in research.”
In 2009, UF became the state’s first recipient of a CTSA. In 2010, a combination of CTSA and state grant funding allowed the CTSI to team up with the FSU College of Medicine to develop new capabilities for community-based clinical research. This collaboration led to creation of the OneFlorida Clinical Research Consortium in 2013, which includes the University of Miami and affiliated health care partners across the state.Friday Letter Submission, Publish on August 02